A Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2556286 in Healthy Adult Participants
Clinical trial NCT04472897 · TERMINATED
Trial details
- NCT number
- NCT04472897
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-30
- Primary completion
- 2024-11-06
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.